Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells

Clinical and Experimental Metastasis

Volumn 20, Issue 7, 2003, Pages 585-592

  Kido, Akira ^a,b   Krueger, Sabine ^a   Haeckel, Carsten ^a   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Aminopeptidase N (APN CD13); Antisense strategy; Metastasis; Osteosarcoma

Indexed keywords

COLLAGEN TYPE 1; GENOMIC DNA; MICROSOMAL AMINOPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL ANCHORAGE; CELL COUNT; CELL INFILTRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ACTIVITY; ENZYME ASSAY; EXPRESSION VECTOR; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; LUNG METASTASIS; METASTASIS INHIBITION; MOLECULAR CLONING; MOUSE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; NUDE MOUSE; OSTEOSARCOMA; OSTEOSARCOMA CELL; POLYMERASE CHAIN REACTION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD13; BONE NEOPLASMS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; DNA, ANTISENSE; DNA, COMPLEMENTARY; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; OSTEOSARCOMA; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0344441775     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027383729767     Document Type: Article

References (31)

1. Nicolson GL. Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Matastasis Rev 1993; 12: 324-43.
2. Liotta LA, Tryggvason K, Garbisa S et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67-8.
3. Liotta LA, Goldfarb RH, Brundage R et al. Effect of plasminogen activator (Urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 1981; 41: 4629-36.
4. Sloane BF, Honn KV, Sadler JG et al. Cathepsin B activity in B16 melanoma cells: A possible marker for metastatic potential. Cancer Res 1982; 42: 980-6.
5. Saiki I, Murata J, Watanabe K et al. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro. Jpn J Cancer Res 1989; 80: 873-8.
6. Sanderink GJ, Artur Y, Siest G. Human aminopeptidases: A review of the literature. J Clin Chem Clin Biochem 1988; 26: 795-807.
7. Look AT, Ashmun RA, Shapiro LH et al. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest 1989; 83: 1299-307.
8. Solhonne B, Gros C, Pollard H et al. Major localization of aminopeptidase M in rat brain. Neuroscience 1987; 22: 225-32.
9. Turner AJ, Hooper NM, Kenny AJ. Metabolism of neutropeptides. In Kenny AJ and Turner AJ (eds): Mammalian Ectoenzymes. New York: Elesevier Scientific Publishing 1984; 211-42.
10. Ward PE, Benter IF, Dick L et al. Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M. Biochem Pharmacol 1990; 40: 1725-32.
11. Falk K, Rotzschke O, Stevanovic S et al. Pool sequencing of natural HLA-DR, -DQ, and -DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immnogenetics 1994; 39: 230-42.
12. Koch AE, Burrows JC, Skoutelis A et al. Monoclonal antibodies detect monocyte/macrophage activation and differentiation antigens and identify functionally distinct subpopulations of human rheumatoid synovial tissue macropharges. Am J Pathol 1991; 138: 165-3.
13. Amoscato AA, Alexander JW, Babcock GF. Surface aminopeptidase activity of human lymphocytes. I. Biochemical and biologic properties of intact cells. J Immunol 1989; 142: 1245-52.
14. Yeager C, Ashmun RA, Williams RK et al. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 1992; 357: 420-2.
15. Lendeckel U, Kahne T, Arndt M et al. Inhibition of alanyl aminopeptidase induces MAP-kinase p43/ERK2 in the human T cell line KARPAS-299. Biochem Biophys Res Commun 1998; 9: 5-9.
16. Saiki I, Fujii H, Yoneda J et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 1993; 54: 137-43.
17. Menrad A, Speicher D, Wacker J et al. Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res 1993; 53: 1450-5.
18. Fujii H, Nakajima M, Saiki I et al. Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13. Clin Exp Metastasis 1995; 13: 337-44.
19. Kido A, Krueger S, Haeckel C et al. Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines. Clin Exp Metastasis 1999; 17: 857-63.
20. Mechtersheimer G, Moller P. Expression of aminopeptidase N (CD13) in mesenchymal tumors. Am J Pathol 1990; 137: 1215-22.
21. Kehlen A, Gohring B, Langner J et al. Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epitherial cells by cytokines and cAMP-increaing mediators. Clin Exp Immunol 1998; 111: 435-41.
22. Soderberg C, Giugni TD, Zaia JA et al. CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol 1993; 67: 6576-85.
23. Turner AJ. Membrane alanyl aminopeptidase. In Barrett AJ, Rawlings ND and Woessner JF (eds): Handbook of Proteolytic Enzymes. San Diego, California: Academic Press 1998; 996-1000.
24. Helene C, Toulme JJ. Specific regulation by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1990; 1049: 99-125.
25. Ino K, Goto S, Okamoto T et al. Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by inhibition of aminopeptidase N activity. Jpn J Cancer Res 1994; 85: 923-33.
26. Murata M, Kubota Y, Tanaka T et al. Effect of ubenimex on the proliferation and differentiation of U937 human histiocytic lymphoma cells. Leukemia 1994; 8: 2188-93.
27. Lohn M, Mueller C, Thiele K et al. Aminopeptidase N-mediated signal transduction and inhibition of human myeloid cells. Adv Exp Med Biol 1997; 421: 85-91.
28. Ota K, Kurita S, Yamada K et al. Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults. Cancer Immunolo Immunother 1986; 23: 5-10.
29. Sekine K, Fujii H, Abe F. Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines. Leukemia 1999; 13: 729-34.
30. Xu Y, Lai LT, Gabrilove JL et al. Antitumor activity of actinonin in vitro and in vivo. Clin Cancer Res 1998; 4: 171-6.
31. Pasqualini R, Koivunen E, Kain R et al. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 2000; 60: 722-7.